Literature DB >> 21987953

Assessment of military population-based psychological resilience programs.

Brenda J Morgan1, Sandra C Garmon Bibb.   

Abstract

Active duty service members' (ADSMs) seemingly poor adaptability to traumatic stressors is a risk to force health. Enhancing the psychological resilience of ADSMs has become a key focus of Department of Defense (DoD) leaders and the numbers of military programs for enhancing psychological resilience have increased. The purpose of this article is to describe the results of an assessment conducted to determine comprehensiveness of current psychological resilience building programs that target ADSMs. A modified six-step, population-based needs assessment was used to evaluate resilience programs designed to meet the psychological needs of the ADSM population. The assessment results revealed a gap in published literature regarding program outcomes. DoD leaders may benefit from targeted predictive research that assesses program effectiveness outcomes. The necessity of including preventive, evidence-based interventions in new programs, such as positive emotion interventions shown to enhance psychological resilience in civilian samples, is also recommended.

Entities:  

Mesh:

Year:  2011        PMID: 21987953     DOI: 10.7205/milmed-d-10-00433

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  Predictors of susceptibility and resilience in an animal model of posttraumatic stress disorder.

Authors:  Carrie A Smith-Bell; Lauren B Burhans; Bernard G Schreurs
Journal:  Behav Neurosci       Date:  2012-12       Impact factor: 1.912

Review 2.  A systematic review of biopsychosocial training programs for the self-management of emotional stress: potential applications for the military.

Authors:  Cindy Crawford; Dawn B Wallerstedt; Raheleh Khorsan; Shawn S Clausen; Wayne B Jonas; Joan A G Walter
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.